DRUG AFFINITIES FOR THE AGONIST AND ANTAGONIST STATES OF THE OPIOID RECEPTOR

被引：5
|
作者：
CHENEY, BV
LAHTI, RA
BARSUHN, C
机构：
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1982年 / 77卷 / 04期
关键词：
D O I：
10.1016/0014-2999(82)90127-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 50 条
  • [1] AFFINITIES OF DRUGS FOR AGONIST AND ANTAGONIST STATES OF DOPAMINE RECEPTOR
    RIDDALL, DR
    LEAVENS, WJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (02) : 187 - 188
  • [2] Pentapeptides Displaying μ Opioid Receptor Agonist and δ Opioid Receptor Partial Agonist/Antagonist Properties
    Purington, Lauren C.
    Pogozheva, Irina D.
    Traynor, John R.
    Mosberg, Henry I.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) : 7724 - 7731
  • [3] Synthesis of kappa opioid receptor agonist/antagonist chemotypes to treat drug addiction
    Taylor, William B.
    Slauson, Stephen
    Rane, Digamber
    Aube, Jeff
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [4] RECOGNITION OF OPIOID AGONIST AND ANTAGONIST IN THE OPIOID RECEPTOR-BINDING SITE
    NOZAKI, M
    NIWA, M
    HASEGAWA, J
    IMAI, E
    HORI, M
    FUJIMURA, H
    LIFE SCIENCES, 1982, 31 (12-1) : 1339 - 1342
  • [5] OPIOID AGONIST AND ANTAGONIST BIVALENT LIGANDS AS RECEPTOR PROBES
    PORTOGHESE, PS
    RONSISVALLE, G
    LARSON, DL
    YIM, CB
    SAYRE, LM
    TAKEMORI, AE
    LIFE SCIENCES, 1982, 31 (12-1) : 1283 - 1286
  • [6] OPIOID RECEPTOR AFFINITY FOR AGONIST-ANTAGONIST ANALGESICS
    JACOBS, AM
    YOUNGBLOOD, F
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1992, 82 (10): : 520 - 524
  • [7] Modulation of gastrointestinal function by MuDelta, a mixed μ opioid receptor agonist/μ opioid receptor antagonist
    Wade, P. R.
    Palmer, J. M.
    McKenney, S.
    Kenigs, V.
    Chevalier, K.
    Moore, B. A.
    Mabus, J. R.
    Saunders, P. R.
    Wallace, N. H.
    Schneider, C. R.
    Kimball, E. S.
    Breslin, H. J.
    He, W.
    Hornby, P. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (05) : 1111 - 1125
  • [8] Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy μ opioid receptor agonist and a δ opioid receptor antagonist
    Mada, Sanjana
    Gerak, Lisa R.
    Soyer, Amelie
    Maguire, David R.
    Hu, Zehua
    Minervini, Vanessa
    Cunningham, Christopher W.
    France, Charles P.
    PSYCHOPHARMACOLOGY, 2020, 237 (12) : 3591 - 3602
  • [9] Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist
    Sanjana Mada
    Lisa R. Gerak
    Amélie Soyer
    David R. Maguire
    Zehua Hu
    Vanessa Minervini
    Christopher W. Cunningham
    Charles P. France
    Psychopharmacology, 2020, 237 : 3591 - 3602
  • [10] DIFFERENTIAL INTERACTION OF THE OPIOID RECEPTOR WITH AGONIST AND ANTAGONIST MORPHINAN DERIVATIVES
    LEMAIRE, S
    BELLEAU, B
    FASEB JOURNAL, 1988, 2 (05): : A1391 - A1391
12345